Overview

Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer

Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to find out the correlation between uridine diphosphate glucuronosyl transferase 1A1(UGT1A1) gene polymorphisms and the side effect and efficacy of irinotecan in patients with small cell lung cancer.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Treatments:
Camptothecin
Irinotecan
Criteria
Inclusion Criteria:

- Clinical diagnosis of refractory or relapsed small cell lung cancer

- Physical examination and routine laboratory tests show no contraindications to
chemotherapy

Exclusion Criteria:

- Pregnant and nursing women

- Brain metastasis with symptoms